Format

Send to

Choose Destination
See comment in PubMed Commons below
Hum Immunol. 2006 Mar;67(3):188-95. Epub 2006 Mar 29.

Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.

Author information

  • 1Department of Internal Medicine II, Eberhard-Karls-University Tübingen, 72076 Tübingen, Germany.

Abstract

MICA, a ligand of the activating immunoreceptor NKG2D, is released by tumor cells in a soluble form and can be detected in sera of tumor patients at significant levels. Soluble MICA has been proposed to counteract NKG2D-mediated immunosurveillance of tumors. Here, we report that MICB, the second member of the human MIC protein family, is likewise shed by metalloproteases from tumor cells and is present in sera of patients with gastrointestinal tumors. While cell-bound MICB causes downregulation of surface NKG2D, soluble MICB did not alter NKG2D expression on NK cells in vitro. Thus, proteolytic shedding of MICB by tumor cells may impair immunogenicity of tumors primarily by reducing NKG2D-ligand densities on malignant cells.

PMID:
16698441
DOI:
10.1016/j.humimm.2006.02.008
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center